Client Overview

Large global pharmaceutical company focused on oncology, cardiology, urology, ophthalmology, hematology, and rare diseases. Company has a novel oncology drug impacting a small percentage of patients in several different tumor types.

Timeframe: Two-years

Project Objective

Increase awareness among HCPs and advocates about new approach of client’s drug.

Challenges

The client’s drug is biomarker-driven, but low number of patients eligible for the drug means widespread testing is not feasible.

Objectives

  • Support patients who have been on drug to form a community for information sharing.
  • Connect patient community with KOLs to expand knowledge and awareness.

Key Strategies Implemented

1

Identified patient opinion leaders, including those active on social media, and recruited to form a global steering committee.

2

Worked with client and steering committee to create educational content, including webinars and an infographic to be translated into multiple languages.

3

Secured a global medical advisory committee to support the patient group and ensure accuracy and independence of all materials.

4

Created website as central hub of information, news, and archived material.

5

Supported steering committee to form independent non-profit entity focused exclusively on patients with relevant biomarker.

Testimonial

"Seeing this group grow from an idea to a non-profit entity with board and scientific advisors was exciting. We now know that patients can connect with peers to learn and find support." Mid-large-size Biopharmaceutical Company

The Outcome

short-term

Short Term

Built a network of patients to inform client and act as spokespersons.

long-term

Long Term

Created new, independent nonprofit with multiple sources of funding, focused on education and support.

key-highlights

Key Highlights

Patient network significantly expanded.
Awareness elevated among other advocacy groups and HCPs.